Residents asked to self-quarantine after roughly 85 people contracted Covid-19 at a Michigan bar – CNN

The total number of Covid-19 infections might be six to 24 times greater than reported, according to a survey of blood samples in 6 areas across the nation performed by the US Centers for Disease Control and Prevention.
The study searched for Covid-19 antibodies in blood samples from business labs– which were collected for reasons unassociated to Covid-19, between March 23 and May 3– in Connecticut, South Florida, the New York City metro area, Missouri, Utah and western Washington State.
In Connecticut, the survey estimated that 5% of individuals had antibodies to Covid-19 between April 26 and May 3, which meant there were six times more cases than reported.
In the New York City city area, that number was 7% of individuals around late March– 12 times greater than the variety of cases reported then. And the survey estimates that 2.65% of Missourians had antibodies in late April. In that case, there were almost 162,000 cases by April 26 in the state– 24 times greater than the 6,800 reported at the time.
CDC Director Dr. Robert Redfield hinted at preliminary results on Thursday when he told press reporters, “The price quotes that we have right now … is thats about 10 times more people have antibody.”
Redfield said that earlier screening efforts may have missed asymptomatic and mild cases, instead focusing on people who were ill in hospitals or nursing houses.
Moving forward: The seroprevalence survey is ongoing, and the CDC states it prepares to test about 1,800 samples every 3 to four weeks from these locations, in addition to 4 extra states: California, Louisiana, Minnesota and Pennsylvania..
The company states these samples may not be representative of the overall populations in these locations, and the survey didnt look at threat elements among those sampled– such as an individuals profession or underlying health conditions.
The study recommends that while the estimated number of infections might be much higher than main numbers, the large bulk of individuals have actually not been contaminated with the infection.
When it comes to what antibodies indicate for immunity to this virus, the jury is still out.
” Other studies are planned to read more about SARS-COV-2 antibodies, including the length of time they last, whether they supply protection against getting infected again, and if you get infected again, whether or not they can make that illness milder,” the company said.
The CDC adjusted its estimates to represent false positive and false unfavorable results, which might take place regularly in some locations, and cautions against analyzing outcomes on a private basis for this factor.